FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely ipratropium bromide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely ipratropium bromide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Leuprorelin acetate 7.5 mg/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Leuprorelin acetate 7.5 mg/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely fructose 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely fructose 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Ipratropium bromide 40 microgram/actuation powder for inhalation Has presentation strength denominator value False un Inferred relationship Some 1
    Ipratropium bromide 40 microgram/actuation powder for inhalation Count of base of active ingredient False un Inferred relationship Some
    Leuprorelin acetate 20 mg/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Leuprorelin acetate 20 mg/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Tetracaine hydrochloride 5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Tetracaine hydrochloride 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Lidocaine hydrochloride 40 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Lidocaine hydrochloride 40 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Tetracaine hydrochloride 10 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Tetracaine hydrochloride 10 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Lidocaine hydrochloride 50 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Lidocaine hydrochloride 50 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely dornase alfa 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dornase alfa 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely dornase alfa 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Indacaterol (as indacaterol maleate) 150 microgram/actuation powder for inhalation Count of base of active ingredient False un Inferred relationship Some
    Indacaterol (as indacaterol maleate) 150 microgram/actuation powder for inhalation Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluoride ion (as sodium fluoride) 2.21 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluoride ion (as sodium fluoride) 2.21 milligram/1 each conventional release oromucosal lozenge (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
    Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 2
    Vaccinia human immune globulin 50 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Vaccinia human immune globulin 50 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely rilonacept 220 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely rilonacept 220 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Hydrocortisone acetate 20 mg/mL cutaneous lotion Count of base of active ingredient False un Inferred relationship Some
    Hydrocortisone acetate 20 mg/mL cutaneous lotion Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluoride ion (as sodium fluoride) 29 milligram/1 gram conventional release oral paste (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluoride ion (as sodium fluoride) 29 milligram/1 gram conventional release oral paste (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Lansoprazole 15 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
    Lansoprazole 15 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Coal tar 100 mg/mL cutaneous solution Count of base of active ingredient False un Inferred relationship Some
    Coal tar 100 mg/mL cutaneous solution Has concentration strength denominator value False un Inferred relationship Some 1
    Lansoprazole 30 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
    Lansoprazole 30 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Glycerol 500 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Glycerol 500 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Diclofenac sodium 250 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Diclofenac sodium 250 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Interferon gamma-1b 200 microgram/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Interferon gamma-1b 200 microgram/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Folic acid 800 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Folic acid 800 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Colistimethate 40 mg/mL solution for inhalation Has concentration strength denominator value False un Inferred relationship Some 1
    Colistimethate 40 mg/mL solution for inhalation Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely folic acid 1 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely folic acid 1 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely folic acid 1 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Hydromorphone hydrochloride 1 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Hydromorphone hydrochloride 1 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Hydromorphone hydrochloride 1 mg/mL solution for injection Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some

    Start Previous Page 194 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start